Citations 3
Response to: Comment on: COG Diagnostic Imaging Committee/SPR Oncology Committee White Papers
Towbin, Alexander J. , Tang, Elizabeth , Thacker, Paul G. , McCarville, M. Beth , Thacker, Paul G , Alazraki, Adina
Pediatric Blood & Cancer | January 31, 2024 | Volume: 71 | Issue: 4 | Pages: No page available
Introduction to the COG Diagnostic Imaging Committee/SPR Oncology Committee White Papers: Rationale and methods
Tang, Elizabeth , Alazraki, Adina , Thacker, Paul G. , McCarville, M. Beth , Towbin, Alexander J. , Alazraki, Adina L
Pediatric Blood & Cancer | May 10, 2023 | Volume: 70 | Issue: S4 | Pages: No page available
AbstractPediatric cancer is a rare disease. Because of this, many sites do not have experience providing imaging for specific tumor types. The Children's Oncology Group Diagnostic Imaging Committee and the Society for Pediatric Radiology Oncology Committee are comprised of radiologists with expertise in pediatric cancer imaging. Recently, this group endeavored to create a series of 23 White Papers designed to provide evidence‐based imaging recommendations and minimum achievable imaging protocols. The purpose of this manuscript is to describe the methods employed in authoring the White Paper series.
Imaging of pediatric liver tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper
Infante, Juan C. , Acord, Michael R. , Davis, James C. , Khanna, Geetika , Morani, Ajaykumar C. , Morin, Cara E. , Nguyen, HaiThuy N. , Rees, Mitchell A. , Squires, Judy , Tang, Elizabeth , Thacker, Paul G. , Towbin, Alexander J. , Schooler, Gary R. , Alazraki, Adina , Chavhan, Govind B. , Davis, James Christopher, Shaikh, Raja , Srinivasan, Abhay S.
Pediatric Blood & Cancer | September 14, 2022 | Volume: 70 | Issue: S4 | Pages: No page available
AbstractPrimary hepatic malignancies are relatively rare in the pediatric population, accounting for approximately 1%–2% of all pediatric tumors. Hepatoblastoma and hepatocellular carcinoma are the most common primary liver malignancies in children under the age of 5 years and over the age of 10 years, respectively. This paper provides consensus‐based imaging recommendations for evaluation of patients with primary hepatic malignancies at diagnosis and follow‐up during and after therapy.